Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.

NCT04483856 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Radiodermatitis
Dermatitis, Radiation-Induced

Interventions

DEVICE: DermoRelizema cream
DEVICE: Dexeryl

Sponsor

Relife Italia S.r.l.